These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3297960)
1. New ideas in thyroid autoimmunity. Pujol-Borrell R; Todd I; Londei M; Feldmann M; Bottazzo GF Horm Res; 1987; 26(1-4):118-24. PubMed ID: 3297960 [TBL] [Abstract][Full Text] [Related]
2. HLA-D/DR expression on epithelial cells: the finger on the trigger? Todd I; Londei M; Pujol-Borrell R; Mirakian R; Feldmann M; Bottazzo GF Ann N Y Acad Sci; 1986; 475():241-50. PubMed ID: 3098153 [TBL] [Abstract][Full Text] [Related]
3. HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Todd I; Pujol-Borrell R; Abdul-Karim BA; Hammond LJ; Feldmann M; Bottazzo GF Clin Exp Immunol; 1987 Sep; 69(3):532-42. PubMed ID: 3117460 [TBL] [Abstract][Full Text] [Related]
4. Thyrocyte HLA class II expression and regulation in relation to thyroid autoimmunity. Todd I; Pujol-Borrell R; Belfiore A; Bottazzo GF Acta Endocrinol Suppl (Copenh); 1987; 281():27-34. PubMed ID: 3497511 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Todd I; Pujol-Borrell R; Hammond LJ; McNally JM; Feldmann M; Bottazzo GF Clin Exp Immunol; 1987 Sep; 69(3):524-31. PubMed ID: 2822302 [TBL] [Abstract][Full Text] [Related]
6. De novo HLA class II and enhanced HLA class I molecule expression in SV40 transfected human thyroid epithelial cells. Belfiore A; Mauerhoff T; Pujol-Borrell R; Badenhoop K; Buscema M; Mirakian R; Bottazzo GF J Autoimmun; 1991 Jun; 4(3):397-414. PubMed ID: 1654916 [TBL] [Abstract][Full Text] [Related]
7. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094 [TBL] [Abstract][Full Text] [Related]
8. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes. Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma. Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. Todd I; Hammond LJ; James RF; Feldmann M; Bottazzo GF Immunology; 1990 Jan; 69(1):91-6. PubMed ID: 2107145 [TBL] [Abstract][Full Text] [Related]
11. Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gamma. Iwatani Y; Iitaka M; Gerstein HC; Row VV; Volpé R J Clin Endocrinol Metab; 1987 Jun; 64(6):1302-8. PubMed ID: 3106398 [TBL] [Abstract][Full Text] [Related]
12. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression. Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838 [TBL] [Abstract][Full Text] [Related]
13. Class II major histocompatibility complex and organ specific autoimmunity in man. Foulis AK J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837 [TBL] [Abstract][Full Text] [Related]
14. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647 [TBL] [Abstract][Full Text] [Related]
15. Inappropriate HLA class II expression on epithelial cells: new insight in the pathogenesis of distinctive autoimmunity. Bottazzo GF; Londei M; Bosi E; Mirakian R; Belfiore A; De Berardinis PG; Todd I; Pujol-Borrell R; Feldmann M Ann Ital Med Int; 1986; 1 Suppl 1():20-3. PubMed ID: 3079434 [No Abstract] [Full Text] [Related]
16. Inhibitory effect of interferon-gamma on the response of human thyrocytes to thyrotropin (TSH) stimulation: relationship between the response to TSH and the expression of DR antigen. Nagayama Y; Izumi M; Ashizawa K; Kiriyama T; Yokoyama N; Morita S; Ohtakara S; Fukuda T; Eguchi K; Morimoto I J Clin Endocrinol Metab; 1987 May; 64(5):949-53. PubMed ID: 3031123 [TBL] [Abstract][Full Text] [Related]
17. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression. Aguayo J; Iitaka M; Row VV; Volpé R J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449 [TBL] [Abstract][Full Text] [Related]
18. Hyperexpression of transporter in antigen processing-1 (TAP-1) in thyroid glands affected by autoimmunity: a contributing factor to the breach of tolerance to thyroid antigens? Sospedra M; Tolosa E; Armengol P; Ashhab Y; Urlinger S; Lucas-Martin A; Foz-Sala M; Jaraquemada D; Pujol-Borrell R Clin Exp Immunol; 1997 Jul; 109(1):98-106. PubMed ID: 9218831 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724 [TBL] [Abstract][Full Text] [Related]